UNICA IRIS Institutional Research Information System

LUSSO, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 14.519
NA - Nord America 3.589
AS - Asia 334
AF - Africa 4
OC - Oceania 4
SA - Sud America 2
Totale 18.452
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 13.689
US - Stati Uniti d'America 3.585
UA - Ucraina 349
CN - Cina 274
SE - Svezia 220
FI - Finlandia 80
GB - Regno Unito 74
DE - Germania 60
IN - India 38
FR - Francia 27
RU - Federazione Russa 16
SG - Singapore 16
TR - Turchia 5
AU - Australia 3
CA - Canada 3
MU - Mauritius 3
NL - Olanda 2
BR - Brasile 1
CL - Cile 1
ES - Italia 1
IE - Irlanda 1
KR - Corea 1
MX - Messico 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 18.452
Salva come PNG Salva come JPEG
Città #
Cagliari 13.520
Woodbridge 536
Fairfield 534
Houston 342
Chandler 315
Ashburn 254
Seattle 239
Ann Arbor 224
Cambridge 203
Wilmington 196
Jacksonville 189
Nyköping 153
Boardman 79
Boston 55
Nanjing 50
San Diego 43
Beijing 35
Milan 31
Verona 29
Pune 27
Shanghai 25
Helsinki 24
Hebei 22
Nanchang 22
Jiaxing 20
Changsha 17
Shenyang 16
Jinan 15
Tianjin 15
Sassari 14
Norwalk 8
Guangzhou 7
London 7
Zhengzhou 7
Mountain View 6
Ningbo 6
Orange 6
Saint Petersburg 5
Redwood City 4
Taizhou 4
Washington 4
Bangalore 3
Dearborn 3
Delhi 3
Kunming 3
New York 3
Paris 3
Tonara 3
Toronto 3
Atlanta 2
Castellammare di Stabia 2
Cedar Knolls 2
Frankfurt am Main 2
Hangzhou 2
Hefei 2
Hounslow 2
Kilburn 2
Legnano 2
Rome 2
San Jose 2
Walnut 2
Auckland 1
Chicago 1
Chiswick 1
Chongqing 1
Ciudad Nezahualcoyotl 1
Denver 1
Dublin 1
Erlangen 1
Geislingen an der Steige 1
Hamburg 1
Lanzhou 1
Leawood 1
Melbourne 1
Miami 1
Millbury 1
Neu-Ulm 1
New Delhi 1
Novokuznetsk 1
Perugia 1
Prescot 1
Qingdao 1
Redmond 1
San Mateo 1
Santiago 1
Silver Spring 1
Singapore 1
Southwark 1
São Paulo 1
Wandsworth 1
Wuhan 1
Totale 17.386
Salva come PNG Salva come JPEG
Nome #
Infection with hepatitis C virus depends on TACSTD2, a regulator of claudin-1 and occludin highly downregulated in hepatocellular carcinoma 1.470
Glycosylation, Hypogammaglobulinemia, and Resistance to Viral Infections 495
Tyrosine sulfation in the second variable loop (V2) of HIV-1 gp120 stabilizes V2-V3 interaction and modulates neutralization sensitivity 492
Chromosomally integrated human herpesvirus 6: questions and answers 489
Enhancement of Anti-HIV-1 Activity by Hot Spot Evolution of RANTES-Derived Peptides 484
Calibration Technologies for Correct Determination of Epstein-Barr Virus, Human Herpesvirus 6 (HHV-6), and HHV-8 Antiviral Drug Susceptibilities by Use of Real-Time-PCR-Based Assays 480
Identification of the platelet-derived chemokine CXCL4/PF-4 as a broad-spectrum HIV-1 inhibitor 470
Selective Reactivation of Human Herpesvirus 6 in Patients With Autoimmune Connective Tissue Diseases 467
Classification of HHV-6A and HHV-6B as distinct viruses 467
Development of a Human Herpesvirus 6 Species-Specific Immunoblotting Assay 466
A new antigen scanning strategy for monitoring HIV-1 specific T-cell immune responses 453
Calibrated real-time polymerase chain reaction for specific quantitation of HHV-6A and HHV-6B in clinical samples 438
The CD8-Derived Chemokine XCL1/Lymphotactin Is a Conformation-Dependent, Broad-Spectrum Inhibitor of HIV-1 433
Treatment with IL-7 Prevents the Decline of Circulating CD4(+) T Cells during the Acute Phase of SIV Infection in Rhesus Macaques 426
HHV-6 encephalitis in umbilical cord blood transplantation: a systematic review and meta-analysis 420
lmmunomodulation and immunosuppression by human herpesvirus 6A and 6B 414
Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4(pos) T cells and macrophages 412
Protein-based HIV-1 microbicides. 409
Molecular study of human herpesvirus 6 and 8 involvement in coronary atherosclerosis and coronary instability 406
Inhibition of HIV-1 Infection by Human alpha-Defensin-5, a Natural Antimicrobial Peptide Expressed in the Genital and Intestinal Mucosae 353
IL-7 induces expression and activation of integrin alpha 4 beta 7 promoting naive T-cell homing to the intestinal mucosa 336
Human herpesvirus 6A accelerates AIDS progression in macaques 298
Evolution of SIV toward RANTES resistance in macaques rapidly progressing to AIDS upon coinfection with HHV-6A 296
The intracellular detection of MIP-1beta enhances the capacity to detect IFN-gamma mediated HIV-1-specific CD8 T-cell responses in a flow cytometric setting providing a sensitive alternative to the ELISPOT 294
Reactivation of human herpesvirus 6 (HHV-6) infection in patients with connective tissue diseases 277
The superior folding of a RANTES analogue expressed in lactobacilli as compared to mammalian cells reveals a promising system to screen new RANTES mutants 275
Biological and physical characterization of the X4 HIV-1 suppressive factor secreted by LPS-stimulated human macrophages 275
Protective versus pathogenic anti-CD4 immunity: insights from the study of natural resistance to HIV infection 274
Engineering of Lactobacillus jensenii to secrete RANTES and a CCR5 antagonist analogue as live HIV-1 blockers 273
A multiplex calibrated real-time PCR assay for quantitation of DNA of EBV-1 and 2 273
Combinatorial optimization of a CD4-mimetic miniprotein and cocrystal structures with HIV-1 gp120 envelope glycoprotein 269
A universal real-time PCR assay for the quantification of group-M HIV-1 proviral load 263
Intraprotomer masking of third variable loop (V3) epitopes by the first and second variable loops (V1V2) within the native HIV-1 envelope glycoprotein trimer 255
Clinical significance of HIV-1 coreceptor usage 254
International network for comparison of HIV neutralization assays: the NeutNet report 253
Broad-Spectrum Inhibition of HIV-1 by a Monoclonal Antibody Directed against a gp120-Induced Epitope of CD4 253
Rational design of novel HIV-1 entry inhibitors by RANTES engineering 251
Molecular engineering of RANTES peptide mimetics with potent anti-HIV-1 activity 248
Identification of RANTES MIP-1 alpha and MIP-1 beta as the major HIV-suppressive factors produced by CD8+ T cells 225
Cryptic nature of a conserved, CD4-inducible V3 loop neutralization epitope in the native envelope glycoprotein oligomer of CCR5-restricted, but not CXCR4-using, primary human immunodeficiency virus type 1 strains 225
HHV-6 and CMV pneumonitis in immunocompromised patients 224
Selective suppression of IL-12 production by human herpesvirus 6 214
Interleukin 7 reduces the levels of spontaneous apoptosis in CD4+ and CD8+ T cells from HIV-1-infected individuals 212
Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection 209
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 205
HHV-6 and the immune system: mechanisms of immunomodulation and viral escape 205
: Alpha-defensins block the early steps of HIV-1 infection: interference with the binding of gp120 to CD4 202
Infection of natural killer cells by human herpesvirus 6 198
CD46 is a cellular receptor for human herpesvirus 6 186
HIV and the chemokine system 186
Enhancement of the HIV-1 inhibitory activity of RANTES by modification of the N-terminal region: dissociation from CCR5 activation 185
In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression 177
Suppression of CCR5- but not CXCR4-tropic HIV-1 in lymphoid tissue by human herpesvirus 6 174
A rationally designed CD4 mimic inhibits HIV-1 entry and exposes cryptic neutralization epitopes 157
Structural determinants of HIV-1 blockade and CCR5 recognition in RANTES 157
Critical role of the N-loop and beta1-strand hydrophobic clusters of RANTES-derived peptides in anti-HIV activity 151
HIV and chemokines: Implications for therapy and vaccines 145
Totale 18.498
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019481 0 0 0 0 0 0 0 0 0 86 197 198
2019/20206.481 547 191 59 189 2.528 1.561 765 253 138 47 74 129
2020/20215.660 213 161 104 2.139 1.687 466 312 213 47 126 122 70
2021/2022652 49 121 39 19 36 15 44 29 64 42 94 100
2022/20231.191 130 115 112 97 101 175 46 127 126 37 55 70
2023/20241.246 120 47 72 172 143 143 86 110 82 271 0 0
Totale 18.498